Get the Stockscreener App
1.38
6.12%
-0.09
Pre-market:
1.50
0.12
+8.70%
Medicus Pharma Ltd stock is traded at $1.38, with a volume of 971.31K.
It is down -6.12% in the last 24 hours and up +20.00% over the past month.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
See More
Previous Close:
$1.47
Open:
$1.53
24h Volume:
971.31K
Relative Volume:
2.34
Market Cap:
$30.86M
Revenue:
-
Net Income/Loss:
$-16.51M
P/E Ratio:
-1.0201
EPS:
-1.3528
Net Cash Flow:
$-15.68M
1W Performance:
+13.11%
1M Performance:
+20.00%
6M Performance:
-24.59%
1Y Performance:
-52.41%
1-Day Range:
$1.35
$1.5453
1-Week Range:
$1.20
$1.70
52-Week Range:
$0.9174
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
Name
Medicus Pharma Ltd
Sector
Industry
Phone
610-540-7515
Address
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Compare MDCX vs LLY, JNJ, ABBV, NVS, AZN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
1.38 | 32.87M | 0 | -16.51M | -15.68M | -1.3528 |
|
LLY
Lilly Eli Co
|
1,003.57 | 899.90B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
245.30 | 594.64B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
236.19 | 413.50B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
NVS
Novartis Ag Adr
|
165.15 | 313.28B | 54.72B | 14.02B | 15.32B | 7.1855 |
|
AZN
Astrazeneca Plc
|
201.53 | 312.88B | 58.80B | 10.24B | 8.98B | 3.2788 |
Medicus Pharma Ltd Stock (MDCX) Latest News
Medicus Pharma on Bloomberg World - Bluffton Today
New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - ACCESS Newswire
Medicus Pharma Showcases SkinJect and Teverelix Strategy at Roth Conference - TipRanks
Medicus Pharma to present at Roth Conference - Proactive financial news
Medicus Pharma To Participate in the 38th Annual Roth Conference - The Manila Times
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform - Treasure Coast News
MDCX PE Ratio & Valuation, Is MDCX Overvalued - Intellectia AI
MDCX Technical Analysis & Stock Price Forecast - Intellectia AI
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - MPNnow.com
MDCX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Reliant AI – Weekly Recap - TipRanks
Can Medicus Pharma Ltd. sustain its profitabilityRate Hike & High Win Rate Trade Alerts - mfd.ru
Aug Technicals: Why is Medicus Pharma Ltd stock going downQuarterly Market Review & AI Forecasted Stock Moves - baoquankhu1.vn
Market Outlook: How is Redwood Trust Inc managing supply chain issuesQuarterly Trade Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Medicus Pharma receives FDA clearance to begin Phase 2b Teverelix study - MSN
Reliant AI Partnership Targets Faster, More Efficient Clinical Trials - TipRanks
Reliant AI Partnership Targets Faster, More Efficient Clinical Trials With Medicus Pharma - TipRanks
Medicus Pharma Receives FDA Clearance to Begin Phase 2b Teverelix Study - MyChesCo
Is Medicus Pharma Ltd. Equity Warrant vulnerable to short sellersShare Buyback & Stepwise Trade Execution Plans - mfd.ru
Does Medicus Pharma Ltd. Equity Warrant have declining or rising EPS2025 Support & Resistance & Fast Entry High Yield Stock Tips - mfd.ru
Medicus Pharma’s Teverelix Phase 2b trial cleared by FDAICYMI - Proactive financial news
Can Medicus Pharma Ltd. Equity Warrant ride the EV waveWeekly Market Outlook & Short-Term High Return Ideas - mfd.ru
Aug Reactions: Is Medicus Pharma Ltd Equity Warrant subject to activist investor interestEarnings Performance Report & High Win Rate Trade Tips - baoquankhu1.vn
Is Medicus Pharma Ltd. Equity Warrant a speculative investmentGold Moves & Low Volatility Stock Suggestions - mfd.ru
Will Medicus Pharma Ltd. Equity Warrant benefit from rising consumer demand2025 Top Decliners & Comprehensive Market Scan Insights - mfd.ru
Why Medicus Pharma Ltd. stock attracts high net worth investorsDollar Strength & High Win Rate Trade Alerts - mfd.ru
Aug Decliners: Is Medicus Pharma Ltd Equity Warrant likely to announce a buybackMarket Trend Review & Short-Term High Return Strategies - baoquankhu1.vn
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement - Asbury Park Press
Analyst Calls: Can Medicus Pharma Ltd stock outperform in a bear marketSell Signal & AI Enhanced Trading Alerts - baoquankhu1.vn
Will Medicus Pharma Ltd. (N460) stock sustain bullish trend into 20252025 AllTime Highs & Short-Term Trading Opportunity Alerts - mfd.ru
MDCX SEC FilingsMedicus Pharma Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Medicus Pharma cleared to launch Phase 2b Teverelix study in Prostate Cancer - Proactive financial news
Medicus Pharma Partners With Gorlin Syndrome Alliance to Expand Access to SKINJECT - MSN
Is Medicus Pharma Ltd. Equity Warrant forming bullish engulfing patterns2025 Key Highlights & Trade Opportunity Analysis - mfd.ru
Medicus Pharma Ltd Stock (MDCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):